Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
440 participants
OBSERVATIONAL
2009-09-30
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Patient characteristics.
* Diagnostic and treatment approaches: initial and subsequent.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiological Study on the Prevalence of Mental Disorders in Slovakia
NCT07129408
Community-based Mental Health Care for People With Severe and Enduring Mental III Health
NCT03922425
Study of Mental Care in Spain
NCT00824031
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
NCT00986531
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Above 18 years
* Signed Informed consent
Exclusion Criteria
* Consent refused
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Burgas, , Bulgaria
Research Site
Pazardzhik, , Bulgaria
Research Site
Sofia, , Bulgaria
Research Site
Stara Zagora, , Bulgaria
Research Site
Varna, , Bulgaria
Research Site
Veliko Tarnovo, , Bulgaria
Research Site
Vidin, , Bulgaria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NBG-SER-2009/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.